Zurich partners with Further to offer serious illness treatment

Zurich has partnered with Further Group to offer investigation and treatment services for cancer, heart, and neurological conditions, including coverage for treatment abroad at leading hospitals.

Accelerate can be added to any new Zurich Life, Critical Illness, or Income Protection Policy at the point of sale or anytime during the life of the policy. It can be canceled at any time, allowing advisers to meet the ongoing and changing needs of their customers.

The offering is designed to provide customers with more choice and control over their healthcare decisions. It provides access to experts from around the world, offering fast access to consultations, diagnostics, and second medical opinions.

Accelerate also helps customers access the latest precision cancer medicine and cancer clinical trials.

Customers can use any of the six services Zurich Accelerate offers, choosing which services to use and when. They have the option to combine them with public or private healthcare, giving them greater control over their healthcare decisions.

Zurich Accelerate is a complimentary service to both public and private healthcare and is not intended to replace either. It provides an alternative route and should be taken up in consultation with their GP.

Customers who access the service will be guided through the entire process by a dedicated, clinically trained case manager. Policyholders’ children will also be automatically covered from birth up to their 22nd birthday.

Zurich will also launch a radio ad in June encouraging people to contact their financial advisers to discuss Zurich Accelerate.